What is a stock summary page? Click here for an overview.
Business Description
Sernova Biotherapeutics Inc
NAICS : 541714
SIC : 3741
ISIN : CA81732W1041
Description
Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.21 | |||||
| Equity-to-Asset | -5.83 | |||||
| Debt-to-Equity | -0.03 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -55.2 | |||||
| 3-Year EPS without NRI Growth Rate | -48.9 | |||||
| 3-Year FCF Growth Rate | -30.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.8 | |||||
| 9-Day RSI | 50.1 | |||||
| 14-Day RSI | 48.26 | |||||
| 3-1 Month Momentum % | -18.27 | |||||
| 6-1 Month Momentum % | -19.18 | |||||
| 12-1 Month Momentum % | -64.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | |||||
| Quick Ratio | 0.1 | |||||
| Cash Ratio | 0.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.6 | |||||
| Shareholder Yield % | -0.48 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -290.73 | |||||
| ROIC % | -1983.02 | |||||
| 3-Year ROIIC % | 4738.19 | |||||
| ROC (Joel Greenblatt) % | -3055.13 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -2.01 | |||||
| EV-to-Forward-EBIT | -2.01 | |||||
| EV-to-EBITDA | -2.04 | |||||
| EV-to-Forward-EBITDA | -2.01 | |||||
| EV-to-FCF | -3.09 | |||||
| Earnings Yield (Greenblatt) % | -49.79 | |||||
| FCF Yield % | -35.08 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sernova Biotherapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.053 | ||
| Beta | 0.67 | ||
| 3-Year Sharpe Ratio | -1.45 | ||
| 3-Year Sortino Ratio | -1.71 | ||
| Volatility % | 41.98 | ||
| 14-Day RSI | 48.26 | ||
| 14-Day ATR (€) | 0.010647 | ||
| 20-Day SMA (€) | 0.107425 | ||
| 12-1 Month Momentum % | -64.81 | ||
| 52-Week Range (€) | 0.0905 - 0.3526 | ||
| Shares Outstanding (Mil) | 328.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sernova Biotherapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sernova Biotherapeutics Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sernova Biotherapeutics Inc Frequently Asked Questions
What is Sernova Biotherapeutics Inc(FRA:PSH0)'s stock price today?
The current price of FRA:PSH0 is €0.11. The 52 week high of FRA:PSH0 is €0.35 and 52 week low is €0.09.
When is next earnings date of Sernova Biotherapeutics Inc(FRA:PSH0)?
The next earnings date of Sernova Biotherapeutics Inc(FRA:PSH0) is .
Does Sernova Biotherapeutics Inc(FRA:PSH0) pay dividends? If so, how much?
Sernova Biotherapeutics Inc(FRA:PSH0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers